The EMA's decision on the marketing authorisation application for Biogen Qalsody...
"With rare exceptions, all 40-year-olds are alike. ... When you have seen one 85...
Tokyo, Japan – Researchers from Tokyo Metropolitan University have engineered a ...
Gene and cell therapies are among the most important innovations in the healthca...
Rapt Therapeutics faces a daunting challenge as the U.S. Food and Drug Administr...
The European Commission has granted its approval to Pfizer’s Velsipity for the t...
The Food and Drug Administration (FDA) has granted approval to AstraZeneca’s Tag...
The emergence of T-cell therapy has revolutionized the treatment of certain bloo...
AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechno...
AbbVie has signed an agreement with Tentarix Biotherapeutics to discover and dev...
The EMA has granted an accelerated review of CHIKV VLP as Bavarian Nordic attemp...
Moderna has reported a net loss of $4.7bn for the full year 2023 as against a ne...
The UK NICE has recommended Pfizer's Ritlecitinib as a new treatment option for ...
The FDA Office of Generic Drugs reported a rise in generic drug approvals, as se...
The positive opinion is based on findings from the Phase III COMMANDS trial whic...
Sanofi and Regeneron’s Dupixent has received priority review by the US FDA, with...
